Gengtao Liu

Title: **Gengtao Liu: Innovator in Pharmaceutical Crystal Forms**

Introduction

Gengtao Liu is a notable inventor based in Hebei Province, China, with a rich background in pharmaceutical research and innovation. He holds two patents that focus on the advanced crystalline forms of fenolamine, which have significant implications in the medical field, particularly in the treatment of neurodegenerative disorders.

Latest Patents

Gengtao Liu's latest innovations include two important patents related to the crystal forms of fenolamine:

1. **Type-G Crystal Form of Fenolamine**: This patent discloses a unique type-G crystal form of fenolamine. It outlines the preparation method and the composition and uses of this crystal form. Specifically, it addresses the solid state of the type-G fenolamine crystal form. This compound serves as a crucial pharmaceutical active ingredient for developing medications aimed at preventing and treating Parkinson's disease (PD), improving learning capabilities, and addressing memory loss pertinent to Alzheimer’s disease (AD).

2. **Type-B Crystal Form of Fenolamine**: Similar to the type-G, this patent covers the type-B crystal form of fenolamine. It provides details on its preparation method, composition, and usage. The type-B fenolamine crystal form is also being investigated for its potential as a pharmaceutical agent for treating conditions like Parkinson's disease and Alzheimer's disease, emphasizing its importance in enhancing memory and learning functions.

Career Highlights

Gengtao Liu has contributed significantly to the field of pharmaceuticals through his work. His experience includes positions at prestigious institutions such as the Chinese Academy of Medical Sciences and Shijiazhuang Yiling Pharmaceutical Co., Ltd. His dedication to research has led to meaningful advancements in medical chemistry and drug formulation.

Collaborations

Throughout his career, Gengtao has collaborated with several esteemed professionals, including Yang Lv and Shiying Yang. These partnerships have facilitated knowledge exchange and further enhanced his innovative pursuits in pharmaceutical research.

Conclusion

Gengtao Liu stands out as a key figure in the field of drug development, utilizing his expertise to create novel pharmaceutical compounds. His patents on the crystalline forms of fenolamine not only reflect his innovative spirit but also promise to improve treatment options for serious neurological disorders. With continued research and collaboration, Gengtao Liu is poised to make even more significant contributions to the pharmaceutical community.